![]() |
New to the Huntington's Disease Lighthouse? |
||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HD Lighthouse Contributing Editor's Comment: -- Janet K. Williams, Ph.D., RN, FAAN Dear Parent of a teen in an HD family ...Janet K. Williams, Ph.D., RN, FAAN
Dear Parent of a teen in an HD family, Many important research studies are being conducted to find better ways to manage or prevent HD. We would like your teen to consider participating in a study to help us understand how to help teens in families where there are persons with HD. The purpose of this HD Family study is to identify the types and frequency of health concerns teens have about the person with HD, personal health concerns that the teen has about him/herself, and what strategies the teen age family member uses to attempt to resolve these problems I, Dr. Janet Williams, am a Registered Nurse who has worked with people with HD and their families, am a Professor of Nursing at The University of Iowa, and am the Principal Investigator of this NIH funded research. Dr. Joan Laing will mail the surveys to family members participating in this study. In the first part of this study, the research team conducted focus groups with teen age HD family members in several cities in the US and in Canada. We developed a survey from the topics from these focus groups. We are now in the process of recruiting participants for the survey study. To be eligible to participate, the teen must be 1) a teen family member of a person with HD or a family member of a person who has had a positive HD test, 2) be between 14-18 years old, and 3) be able to read English. The surveys ask your teen to provide information about him/herself and the person with HD or a positive HD test, to indicate health concerns about the person with HD, to indicate personal health concerns the teen has about him/herself, and to indicate what strategies he/she uses to try to solve these problems. It may take between 30-60 minutes to complete the survey. If your teen family members would like to participate in this study, you can receive further information, or receive the survey by contacting Dr. Joan Laing at The University of Iowa. She will ask you how many teens in your family would like to receive a copy of the survey. Each teen who returns the survey will receive either a $25.00 iTunes gift certificate, or a $25.00 Radio Shack gift certificate as a token of our appreciation. The survey will ask your teen about him/herself, and about the person in your family with HD. It is possible that your teen may experience emotional distress when reading questions on the survey. He/she should feel free to skip any questions that cause distress, or that they do not want to answer. Some of the surveys that your teen will complete ask about his/her outlook of the future and their mood. If our research team is concerned about the health or distress of the survey respondent we will recommend to you and to your teen that your teen seek help to address the concerns. If you or your teen feel at any time that your teen could benefit from treatment or support, you can contact Dr. Williams to be referred to a specialist. Finally, you should understand that we are not prevented from taking steps, including reporting to authorities, to prevent serious harm to your teen. Your teen will not benefit personally from completing the surveys. However we hope that other teens in HD families may benefit in the future from what we learn as a result of this study. If you have questions about the rights of research subjects, please contact the Human Subjects Office, 300 College of Medicine Administration Building, The University of Iowa, Iowa City, IA 52242, 319-335-6564, or e-mail irb@uiowa.edu. If teens in your family who are 14-18 years old would like to receive a survey, please contact Dr. Joan Laing at 319-353-5414, joan-laing@uiowa.edu; or by returning the response form. Thank you for considering participating in this opportunity to help families as well as people who have HD. Janet K. Williams, Ph.D., RN, FAAN Joan Laing, PhD Source: Public announcement
|
Research focusing on the formation of aggregates caused by HD
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
Research related HD and it's general affect on the brain
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
Research focusing on gene therapy.
Research focusing on gene transcription.
General research related to HD
Research studying the genetics of Huntington's Disease
Research studying the Immune System and it's effect on the progression of HD
Research studying the brain tissue and research related to stem cells
9 Jun 2008
The Research Pipeline - taking drugs from the lab to the clinic
Here's an overview of some of the more promising potential treatments moving through the research pipeline. 12 Mar 2008
Phase III creatine trial
NCCAM and the Orphan Product Division of the FDA is funding a phase III clinical trial of medicinal grade creatine. 1 Oct 2007
ACR16 closer to Phase III clinical trials
Neurosearch applies for permission to start Phase III clinical trials of ACR16, a dopamine stabilizer, in Europe and the U.S. 30 Sep 2007
Research Study for those At Risk
Last call for participants in an At Risk study. 19 Aug 2007
Riluzole Found Ineffective for Huntington's Disease Patients
A Phase III clinical trial of the glutamate blocker riluzole failed to slow progression or improve symptoms in HD patients.
1 Aug 2007
Daniel P. Van Kammen, MD, Phd, to lead CHDI Huntington's Disease Clinical Development Effort
MRSSI, Inc. announced today that Daniel P. van Kammen MD, PhD has joined as Chief Medical Officer.
31 Jul 2007
HD Study for Those At Risk
John Hopkins University and the National Human Genome Research Institute are starting a new study for those at risk.
28 Jul 2007
HSG to Conduct a Phase 2 Study in Adults with Mild-to-Moderate Huntington Disease
HSG announces a Phase II study of Dimebon
5 Feb 2007
Miraxion Study Completed, Results Soon
Amarin Corp. and the HSG have completed a Phase III clinical trial of Miraxion which investigated whether the drug improves motor symptoms in HD.
16 Jan 2007
Creatine trials
Avicena is planning a phase II toxicology trial for its creatine product followed soon by a phase III trial.
All Updates for Clinical Trials | ||||||||||||||||||||||
| Disclaimer & Privacy
Policy | |
|